Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia

Condition:   Atypical Ductal Hyperplasia Intervention:   Device: Contrast enhanced mammography Sponsors:   Dana-Farber Cancer Institute;   GE Healthcare Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials